Medical Equipment Research

A.C.T.S.
(Abnormal Cell Targeting Solutions)

Currently accepting applications for pancreatic cancer pilot study.

1) Pilot studies are in the Portland, Maine area.

2) Successful candidates will continue ongoing prescribed treatments.

3) Study length is one month (four weeks).

4) Candidates must be available three nights per week for approximately 15 minutes each scheduled meeting time.

5) 100% compliant candidates (scheduled meeting times) will receive a $100 visa card upon completion of the study.

For additional information, please contact us at:
 
actstudy@qualight.com

Room Temperature Superconductor Research

Since the discovery of the superconductivity property in mercury by Dutch physicist Heike Kamerlingh Onnes, Leiden University, in 1911, the field of superconductivity has been constantly evolving as new engineered materials are developed, pushing the temperature limits of superconductivity to new levels.

In 1986, Alex Müller and Georg Bednorz, IBM Research Laboratory, Rüschlikon, Switzerland, discovered superconducting properties (Tc = 30-58 K) in a synthesized Lanthanum, Barium, Copper and Oxygen compound. Prior to this discovery,ceramic compounds were not being considered viable candidates for high-temperature superconductors due to their normally insulative properties.

The world record Tc of 138 K is now held by a thallium-doped, mercuric-cuprate material comprised of the elements Mercury, Thallium, Barium, Calcium, Copper and Oxygen. The Tc of this ceramic superconductor was confirmed by Dr. Ron Goldfarb at the National Institute of Standards and Technology-Colorado in February of 1994. Under extreme pressure its Tc can be coaxed up even higher - approximately 25 to 30 degrees more at 300,000 atmospheres.

Qualight is actively involved in high-temperature superconductor materials research.